DekaBank Deutsche Girozentrale’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Hold |
15,503
| – | – | ﹤0.01% | 729 |
|
|
2025
Q1 | $2.82M | Hold |
15,503
| – | – | 0.01% | 669 |
|
|
2024
Q4 | $2.44M | Hold |
15,503
| – | – | ﹤0.01% | 708 |
|
|
2024
Q3 | $2.72M | Hold |
15,503
| – | – | 0.01% | 699 |
|
|
2024
Q2 | $2.83M | Hold |
15,503
| – | – | 0.01% | 686 |
|
|
2024
Q1 | $2.71M | Hold |
15,503
| – | – | 0.01% | 696 |
|
|
2023
Q4 | $1.97M | Hold |
15,503
| – | – | ﹤0.01% | 776 |
|
|
2023
Q3 | $1.81M | Sell |
15,503
-14,797
| -49% | -$1.72M | ﹤0.01% | 766 |
|
|
2023
Q2 | $3.47M | Hold |
30,300
| – | – | 0.01% | 633 |
|
|
2023
Q1 | $2.35M | Hold |
30,300
| – | – | 0.01% | 696 |
|
|
2022
Q4 | $2.38M | Hold |
30,300
| – | – | 0.01% | 684 |
|
|
2022
Q3 | $2.11M | Hold |
30,300
| – | – | 0.01% | 698 |
|
|
2022
Q2 | $1.92M | Buy |
30,300
+5,000
| +20% | +$316K | 0.01% | 738 |
|
|
2022
Q1 | $1.69M | Buy |
25,300
+16,500
| +188% | +$1.1M | ﹤0.01% | 792 |
|
|
2021
Q4 | $619K | Buy |
8,800
+200
| +2% | +$14.1K | ﹤0.01% | 1049 |
|
|
2021
Q3 | $453K | Hold |
8,600
| – | – | ﹤0.01% | 1073 |
|
|
2021
Q2 | $586K | Hold |
8,600
| – | – | ﹤0.01% | 1039 |
|
|
2021
Q1 | $622K | Buy |
8,600
+2,200
| +34% | +$159K | ﹤0.01% | 990 |
|
|
2020
Q4 | $361K | Buy |
+6,400
| New | +$361K | ﹤0.01% | 1089 |
|